Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol

• Clemens Warnke,
• Stephanie Stock,
• Martin Hellmich,
• Gereon R Fink,
• Heidrun Golla,
• Raymond Voltz,
• Judith Haas,
• Julia Strupp,
• Volker Limmroth,
• Anne Müller,
• Eckhard Bonmann,
• Kim Dillen,
• Thomas Dojan,
• Solveig Ungeheuer,
• Petra Schmalz,
• Angelika Staß,
• Vanessa Mildenberger,
• Yasemin Goereci,
• Veronika Dunkl,
• Oliver Cornely,
• Alexander Stahmann,
• Peter Löcherbach,
• Lothar Burghaus,
• Kathrin Gerbershagen,
• Gereon Nelles,
• Thomas Joist,
• Herbert Temmes

Affiliations

Clemens Warnke

Department of Neurology, University of Cologne, Cologne, Nordrhein-Westfalen, Germany

Stephanie Stock

Institute for Health Economics and Clinical Epidemiology (IGKE), University of Cologne, Cologne, Germany

Martin Hellmich

Institute of Medical Statistics and Computational Biology (IMSB), University of Cologne, Cologne, Germany

Gereon R Fink

Department of Neurology, University of Cologne, Cologne, Nordrhein-Westfalen, Germany

Heidrun Golla

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Raymond Voltz

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Judith Haas

German Multiple Sclerosis Society Federal Association (DMSG), Hannover, Germany

Julia Strupp

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Volker Limmroth

Department of Neurology, Klinikum Köln, Cologne, Germany

Anne Müller

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Eckhard Bonmann

Department of Neurology, Klinikum Köln, Cologne, Germany

Kim Dillen

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Thomas Dojan

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Solveig Ungeheuer

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Petra Schmalz

Clinical Trials Centre Cologne (CTCC), University of Cologne, Cologne, Germany

Angelika Staß

Clinical Trials Centre Cologne (CTCC), University of Cologne, Cologne, Germany

Vanessa Mildenberger

Institute for Health Economics and Clinical Epidemiology (IGKE), University of Cologne, Cologne, Germany

Yasemin Goereci

Department of Neurology, University of Cologne, Cologne, Nordrhein-Westfalen, Germany

Veronika Dunkl

Department of Palliative Medicine, University of Cologne, Cologne, Germany

Oliver Cornely

Clinical Trials Centre Cologne (CTCC), University of Cologne, Cologne, Germany

Alexander Stahmann

MS-Registry by the German MS-Society, MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany

Peter Löcherbach

German Society for Care and Case Management (DGCC), Mainz, Germany

Lothar Burghaus

Department of Neurology, Heilig Geist-Krankenhaus Köln, Cologne, Germany

Kathrin Gerbershagen

Department of Neurology, Klinikum Köln, Cologne, Germany

Gereon Nelles

NeuroMed Campus, MedCampus Hohenlind, Cologne, Germany

Thomas Joist

Academic Teaching Practice, University of Cologne, Cologne, Germany

Herbert Temmes

German Multiple Sclerosis Society Federal Association (DMSG), Hannover, Germany